Biogen Inc
Drug Manufacturers - General
Healthcare
BIIB
146 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
126.30
52 week high
201.44
high
127.98
52 week low
113.38
low
125.13
growth
-34.92 %
previous Close
126.31
P/E ratio
31
market cap
21.77 B
div yield
0
usd
Sep 2024
qoq
revenue
2.47 B
4.79 %
net incoming
389 M
-33.43 %
eps
4.08 %
-22.73 %
eps surprise
7.65 %
net profit margin
15.76 %
-9.00 %
operating incoming
496 M
-23.91 %
net change in cash
-209.70 M
-125.13 %
cash on hand
1.70 B
-10.99 %
cost of revenue
639 M
-9.38 %
top top